Maintaining a balanced oral microbiome is crucial during the whole year, but it is especially important when children return from holidays and are about to start the season of kindergarten and school. This period is considered as a high risk for developing ENT infections, including otitis media.
A multicenter, randomized clinical study provides further validation for our category leader Bactoblis®, in reducing the recurrence of ENT infections and otitis media in children aged 3-12 years. Here are the key findings:
– 92% reduction of ENT infections and 40% decrease in acute otitis media after 3 month treatment with Bactoblis®.
– 66% reduction of the pharyngeal and ear infections incidence after a 6 month follow up period of Bactoblis® treatment.
–Excellent accpetance in children, with no reported side effects or dropouts
Read the full study by Di. Pierro et al 2012 by clicking here.
